Download flyer: Quality Primary Antibodies with Extensive Validation by OriGene
OriGene offers a broad selection of monoclonal and polyclonal antibodies to human proteins for various immuno-detections. Products include (1) 140,000 primary antibodies target critical proteins covering various pathways; (2) 27,000 OriGene branded antibodies: TrueMAB®, UltraMAB®,TrueRAB™ and TrueMAB™ with extensive validation data and large citations; (3) 600 Knock Out (KO) validated antibodies covering important immune-oncology targets; (4) Positive controls are available for most antibodies; (5) Large selection of anti-tag antibodies include common epitope tags and fluorescent protein tags; (6) Large selection of loading control antibodies against GAPDH, beta-tubulin, beta-actin and HSP90AB for several species.
Let’s start your product search today from the comprehensive antibodies library!
ABOUT ORIGENE
OriGene empowers researchers in their journey to move from Genomics to Proteomics.
OriGene, a global research tool company, offers a range of research tools for genome and proteome analysis which include cDNA clones, antibodies, recombinant proteins and custom services.
25 Years Strong
In 1996, OriGene Technologies was founded as a research tool company focused on the creation of the large commercial collection of full-length human cDNAs with a mission to be “Your Gene Company”, supplying you with all tools for gene-based research. Today we have stayed true to our mission, continuing to develop high quality innovative tools based on our strong proprietary cDNA clone collection.
OriGene Forging Ahead: Moving from Genomics to Proteomics
Current OriGene product portfolio has over a million products that enable scientists analyze the proteome universe. It includes four key brands: MVPro, TrueRAB, TrueMAB and our ultra-specific antibodies UltraMAB. In addition, we recently launched CytoSection, the novel control for IHC, ICC and ISH. Today researchers can start their journey with a clone from our TrueClone collection and complete the analysis by developing an assay system using our Ultra-Specific antibodies. We empower researchers in their journey to move from Genomics to Proteomics.
